Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Correction to: HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction induced injury

Correction to: HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric... Billin et al. Skeletal Muscle (2018) 8:38 https://doi.org/10.1186/s13395-018-0185-7 CORRECTION Open Access Correction to: HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction induced injury 1† 1† 1 1 1 Andrew N. Billin , Samuel E. Honeycutt , Alan V. McDougal , Jaclyn P. Kerr , Zhe Chen , 3 3 1 1 3 4 Johannes M. Freudenberg , Deepak K. Rajpal , Guizhen Luo , Henning Fritz Kramer , Robert S. Geske , Frank Fang , 2 1 2 2 1 5 1 Bert Yao , Richard V. Clark , John Lepore , Alex Cobitz , Ram Miller , Kazunori Nosaka , Aaron C. Hinken and 1* Alan J. Russell Correction to: Skeletal Muscle (2018) 8:35 https://doi.org/10.1186/s13395-018-0179-5 Reference Following publication of the original article [1], the 1. Billin AN, et al. HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction induced injury. Skelet Muscle. 2018;8:35. https:// authors flagged that there is a discrepancy with the doi.org/10.1186/s13395-018-0179-5. Availability of data and materials statement on page 12 of the article. This statement says that “Raw preclinical and clin- ical data for this manuscript will not be shared for logistical reasons.” However, the authors state on page 10 of the article that “Anonymized individual participant data and study documents can be requested for further research from www.clinicalstudydatarequest.com.” The policy at GlaxoSmithKline, Inc., the sponsor of this paper (see the Funding section on page 12), is consistent with the latter statement, of page 10. As such, in the interest of full transparency, please be advised that the Availability of data and materials statement on page 12 of the article is void. Author details Muscle Metabolism Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA. Metabolic Pathways and Cardiovascular Therapy Area, GlaxoSmithKline, King of Prussia, PA, USA. Target Sciences, GlaxoSmithKline, King of Prussia, PA, USA. Clinical Statistics, GlaxoSmithKline, King of Prussia, PA, USA. School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia. * Correspondence: arussell@edgewisetx.com Andrew N. Billin and Samuel E. Honeycutt contributed equally to this work. Muscle Metabolism Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Skeletal Muscle Springer Journals

Loading next page...
 
/lp/springer-journals/correction-to-hif-prolyl-hydroxylase-inhibition-protects-skeletal-IrO0gnPtVO
Publisher
Springer Journals
Copyright
Copyright © 2018 by The Author(s).
Subject
Life Sciences; Cell Biology; Developmental Biology; Biochemistry, general; Systems Biology; Biotechnology
eISSN
2044-5040
DOI
10.1186/s13395-018-0185-7
Publisher site
See Article on Publisher Site

Abstract

Billin et al. Skeletal Muscle (2018) 8:38 https://doi.org/10.1186/s13395-018-0185-7 CORRECTION Open Access Correction to: HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction induced injury 1† 1† 1 1 1 Andrew N. Billin , Samuel E. Honeycutt , Alan V. McDougal , Jaclyn P. Kerr , Zhe Chen , 3 3 1 1 3 4 Johannes M. Freudenberg , Deepak K. Rajpal , Guizhen Luo , Henning Fritz Kramer , Robert S. Geske , Frank Fang , 2 1 2 2 1 5 1 Bert Yao , Richard V. Clark , John Lepore , Alex Cobitz , Ram Miller , Kazunori Nosaka , Aaron C. Hinken and 1* Alan J. Russell Correction to: Skeletal Muscle (2018) 8:35 https://doi.org/10.1186/s13395-018-0179-5 Reference Following publication of the original article [1], the 1. Billin AN, et al. HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction induced injury. Skelet Muscle. 2018;8:35. https:// authors flagged that there is a discrepancy with the doi.org/10.1186/s13395-018-0179-5. Availability of data and materials statement on page 12 of the article. This statement says that “Raw preclinical and clin- ical data for this manuscript will not be shared for logistical reasons.” However, the authors state on page 10 of the article that “Anonymized individual participant data and study documents can be requested for further research from www.clinicalstudydatarequest.com.” The policy at GlaxoSmithKline, Inc., the sponsor of this paper (see the Funding section on page 12), is consistent with the latter statement, of page 10. As such, in the interest of full transparency, please be advised that the Availability of data and materials statement on page 12 of the article is void. Author details Muscle Metabolism Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA. Metabolic Pathways and Cardiovascular Therapy Area, GlaxoSmithKline, King of Prussia, PA, USA. Target Sciences, GlaxoSmithKline, King of Prussia, PA, USA. Clinical Statistics, GlaxoSmithKline, King of Prussia, PA, USA. School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia. * Correspondence: arussell@edgewisetx.com Andrew N. Billin and Samuel E. Honeycutt contributed equally to this work. Muscle Metabolism Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Journal

Skeletal MuscleSpringer Journals

Published: Dec 10, 2018

References